RNA interference in ocular indications
US11584933B2 · kind B2 · utility
1Cited by
215References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 12, 2020 |
| Grant date | Feb 21, 2023 |
| Priority date | — |
| Expiry date | Jun 18, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/32
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to ocular administration of sd-rxRNA and rxRNAori molecules.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.